Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?

Journal of Hepatology

Volumn 49, Issue 5, 2008, Pages 862-863

  Deterding, Katja ^a   Manns, Michael P ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; TENOFOVIR; VIRUS DNA;

COMBINATION CHEMOTHERAPY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; LETTER; MONOTHERAPY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS LOAD; VIRUS MUTATION;

ADENINE; ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENETIC VARIATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; TREATMENT FAILURE;

EID: 53249154274     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.08.001     Document Type: Letter

References (7)

1. Tan J., Degertekin B., Wong S.N., Husain M., Oberhelman K., and Lok A.S. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. J Hepatol 48 (2008) 391-398
2. Cornberg M., Protzer U., Dollinger M.M., Petersen J., Wedemeyer H., Berg T., et al. Prophylaxis, diagnosis and therapy of hepatitis-B-virus- (HBV-) infection: upgrade of the guideline, AWMF-Register 021/011. Z Gastroenterol 45 (2007) 525-574
3. Angus P., Vaughan R., Xiong S., Yang H., Delaney W., Gibbs C., et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125 (2003) 292-297
4. Villeneuve J.P., Durantel D., Durantel S., Westland C., Xiong S., Brosgart C.L., et al. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. J Hepatol 39 (2003) 1085-1089
5. Qi X., Xiong S., Yang H., Miller M., and Delaney W.E. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther 12 (2007) 355-362
6. Villet S., Pichoud C., Billioud G., Barraud L., Durantel S., Trepo C., et al. Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J Hepatol 48 (2008) 747-755
7. Gerolami R., Bourliere M., Colson P., Halfon P., Borentain P., Henry M., et al. Unusual selection of rtA181V HBV mutants cross-resistant to adefovir following prolonged lamivudine monotherapy: report of two cases. Antivir Ther 11 (2006) 1103-1106